What does gross profit mean?

Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Theravance Biopharma TBPH Gross Profit

Discontinued — last reported Q4 '17

Gross Profit at other companies

Zevra Therapeutics, Inc.ZVRA

$34.32M+80.1%

LQD

Liquidia CorporationLQDA

$1.6M+6.5%

Aurinia PharmaceuticalsAUPH

$71.2M+32.1%

OrganonOGN

$783M-6.9%

United TherapeuticsUTHR

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$890.32M+67.5%

Enterprise value$642.72M+37.0%

P/E7.8×—

P/S8.1×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Calculated from Theravance Biopharma’s reported figures.

$4.5Mtotal revenue−$3.1Mtotal cost of revenue=$1.4M

The official record: Theravance Biopharma’s 10-K, filed February 27, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.